Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imexon plus Dacarbazine in Advanced Melanoma
NCT00327600Phase 2Completed
- Sponsor
- AmpliMed Corporation
- Start
- Jul 2005
- Primary completion
- Jan 2007
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of imexon in Malignant Melanoma (MM), sponsored by AmpliMed Corporation. Started Jul 2005; status: completed.
02
Drugs
imexon
03
Conditions
Malignant Melanoma (MM)
Beyond the preview
Go deeper on NCT00327600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00327600.